Dr Neil Love відкриті
[search 0]
більше

Download the App!

show episodes
 
Loading …
show series
 
Dr Arnon Kater from the Amsterdam University Medical Centers in Amsterdam discusses recent advances in the management of chronic lymphocytic leukemia. CME information and select publications here.Research To Practice
 
Dr Michael Savona from Vanderbilt University School of Medicine in Nashville, Tennessee, discusses recent advances and future directions in the management of myelodysplastic syndromes. CME information and select publications here.Research To Practice
 
Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma. CME information and select publications here.Research To Practice
 
Dr Marcia Brose from the Sidney Kimmel Cancer Center in Philadelphia discusses the latest clinical data on targeted therapeutic approaches for the management of advanced thyroid cancer. CME information and select publications here.Research To Practice
 
Dr Samuel Klempner from Massachusetts General Hospital in Boston, Massachusetts discusses recent updates on immunotherapy and targeted therapy for gastroesophageal cancers. CME information and select publications here.Research To Practice
 
Dr Ian Krop from the Dana-Farber Cancer Institute in Boston discusses recently published and emerging research on the treatment of HER2-low breast cancer. CME information and select publications here.Research To Practice
 
Dr Kathleen Moore from the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, discusses key presentations on gynecologic cancers from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Lori Wirth from the Massachusetts General Hospital in Boston discusses the latest clinical data and ongoing investigations on targeted therapeutic approaches for the management of RET-altered and NTRK fusion-positive thyroid cancers. CME information and select publications here.Research To Practice
 
Dr Joel Neal from Stanford University in Stanford, California, discusses key presentations on lung cancer from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Jesús Berdeja from the Sarah Cannon Research Institute in Nashville, Tennessee, discusses recent advances and future directions in the use of CAR T-cell therapy for the management of multiple myeloma. CME information and select publications here.Research To Practice
 
Dr Kristen Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, discusses key presentations on gastrointestinal cancers from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses key presentations on breast cancer from the 2021 ASCO Annual meeting. CME information and select publications here.Research To Practice
 
Dr Jaffer Ajani from MD Anderson Cancer Center in Houston, Texas discusses the latest clinical data on immune checkpoint inhibitors and other novel agents in the management of gastroesophageal cancers. CME information and select publications here.Research To Practice
 
Dr Arjun Balar from the NYU Perlmutter Cancer Center in New York discusses key presentations on genitourinary cancers from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Guillermo Garcia-Manero from the MD Anderson Cancer Center discusses clinical data with new and emerging approaches for the management of myelodysplastic syndromes. CME information and select publications here.Research To Practice
 
Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer. CME information and select publications here.Research To Practice
 
Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer. CME information and select publications here.Research To Practice
 
Dr Morie Gertz from the Mayo Clinic in Rochester, Minnesota, discusses the diagnosis and management of amyloid light chain amyloidosis. CME information and select publications here.Research To Practice
 
Mitesh Borad from the Mayo Clinic Comprehensive Cancer Center in Scottsdale, Arizona, discusses the biology of cholangiocarcinoma and clinical data with new and emerging targeted approaches for patients with this disease. CME information and select publications here.Research To Practice
 
Dr Roy Herbst from the Yale Cancer Center discusses the clinical data on and optimal use of adjuvant osimertinib for patients with resected non-small cell lung cancer and an EGFR mutation. CME information and select publications here.Research To Practice
 
Dr Laurie Sehn from the BC Cancer Center for Lymphoid Cancer in Vancouver, Canada, discusses the latest clinical research findings on non-Hodgkin and Hodgkin lymphomas from the 2020 ASH Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Natalie Callander from the University of Wisconsin Carbone Cancer Center discusses key presentations on multiple myeloma, Waldenström macroglobulinemia and amyloidosis from the 2020 ASH Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Roberto Iacovelli from the Fondazione Policlinico Universitario A Gemelli in Rome discusses the spectrum and management of side effects with hormonal therapies in prostate cancer. CME information and select publications here.Research To Practice
 
Dr Harry Erba from Duke University in Durham, North Carolina, discusses key presentations on acute myeloid leukemia and myelodysplastic syndromes from the 2020 AS Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Manmeet Ahluwalia from the Miami Cancer Institute of Baptist Health South Florida discusses recently published and emerging research on the management of CNS metastases in patients with non-small cell lung cancer. CME information and select publications here.Research To Practice
 
Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York discusses recently published and emerging research on the treatment of diffuse large B-cell lymphoma. CME information and select publications here.Research To Practice
 
Dr Andrew Wei from the Alfred Hospital and Monash University in Melbourne, Australia, discusses recently published and emerging research on the treatment of acute myeloid leukemia not eligible for intensive induction therapy. CME information and select publications here.Research To Practice
 
Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid discusses the latest clinical data on and optimal integration of PARP inhibitors in ovarian cancer. CME information and select publications here.Research To Practice
 
Professor Solange Peters from Lausanne University Hospital in Switzerland discusses existing and emerging biomarkers of response to cancer immunotherapy. CME information and select publications here.Research To Practice
 
Dr Joseph Mikhael from the Translational Genomics Research Institute in Phoenix, Arizona, discusses agents that have been recently approved for the treatment of multiple myeloma. CME information and select publications here.Research To Practice
 
Dr Zofia Piotrowska from the Massachusetts General Hospital in Boston discusses emerging strategies for patients with non-small cell lung cancer and EGFR exon 20 insertion mutations. CME information and select publications here.Research To Practice
 
Dr Mark Pegram from the Stanford University School of Medicine discusses the latest clinical data on and optimal use of newly approved therapies for HER2-positive metastatic breast cancer. CME information and select publications here.Research To Practice
 
Dr Shaji Kumar from the Mayo Clinic in Rochester, Minnesota, and Dr Philip Thompson from the University of Texas MD Anderson Cancer Center discuss the role of minimal residual disease assessment in the management of multiple myeloma and chronic lymphocytic leukemia. CME information and select publications here.…
 
Dr Erika Hamilton from the Sarah Cannon Research Institute in Nashville discusses the latest clinical data on and optimal management of ER-positive metastatic breast cancer. CME and select publications here.Research To Practice
 
Dr Ann LaCasce from the Dana-Farber Cancer Institute discusses key presentations on chronic lymphocytic leukemia and follicular lymphoma from the 2020 ASH Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Kathleen Moore from the University of Oklahoma Health Sciences Center discusses key 2020 presentations on the role of PARP inhibitors and other treatment strategies in the management of advanced ovarian cancer. CME information and select publications here.Research To Practice
 
Dr Steven Coutre from Stanford Medicine in California discusses recently published and emerging research in the front-line treatment of chronic lymphocytic leukemia. CME information and select publications here.Research To Practice
 
Dr Aaron Gerds from the Cleveland Clinic Taussig Cancer Institute discusses key presentations on myeloproliferative neoplasms from the 2020 ASH Annual Meeting. CME information and select publications here.Research To Practice
 
Dr Matthew Galsky from the Icahn School of Medicine at Mount Sinai in New York discusses recently published and emerging data on newly approved agents for urothelial bladder carcinoma. CME information and select publications hereResearch To Practice
 
Dr Corey Langer from the Abramson Cancer Center at the University of Pennsylvania discusses recently published and emerging data on the role of immune checkpoint inhibitors in the treatment of metastatic non-small cell lung cancer without actionable mutations. CME information and select publications here…
 
Dr Shannon Westin from the MD Anderson Cancer Center in Houston, Texas, discusses the role of PARP inhibition in the management of ovarian cancer. CME information and select publications hereResearch To Practice
 
Dr Sagar Lonial from the Winship Cancer Institute in Atlanta, Georgia, discuses key presentations on the management of multiple myeloma from the 2020 ASH Annual Meeting. CME information and select publications hereResearch To Practice
 
Dr David Quinn from the University of Southern California in Los Angeles discusses the impact of COVID-19 on the management of cancer and the current challenges he is experiencing as a physician caring for patients at the front line of the pandemic. Additional resources Lee LYW et al. COVID-19 mortality in patients with cancer on chemotherapy or ot…
 
Dr Marjorie Zauderer from Memorial Sloan Kettering Cancer Center in New York discusses recently published and emerging research in the management of mesothelioma. CME information and select publications here.Research To Practice
 
Dr Stephen Liu from Georgetown University Hospital in Washington, DC, discusses recently published and emerging research on the role of immunotherapy combination approaches in the treatment of metastatic non-small cell lung cancer. CME information and select publications here.Research To Practice
 
Loading …

Короткий довідник

Google login Twitter login Classic login